Patent · US Active

Thienopyrimidones

US11136336B2 · kind B2 · utility

1Cited by

0References

12Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Martin Fleck · Warthausen, DE
Florian Paul Christian Binder · Maselheim, DE
Georg Dahmann · Biberach an der Riß, DE
Joerg P. Hehn · Biberach an der Riß, DE
Annekatrin Heimann · Biberach, DE
Jens WILLWACHER · Biberach an der Riß, DE

Key dates

Filing date	Oct 15, 2020
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Oct 15, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to thienopyrimidinones and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of fibrotic diseases, inflammatory and auto-immune diseases and CNS-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.